DNA Link Inc (127120) — Cash Flow Reinvestment Rate
DNA Link Inc (127120) has a Cash Flow Reinvestment Rate of 1.64x as of December 2023, reinvesting ₩2.48 Billion (capex ₩786.91 Million plus investments ₩-1.69 Billion) from operating cash flow of ₩1.51 Billion. See how much free cash does DNA Link Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DNA Link Inc Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for DNA Link Inc across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of DNA Link Inc.
Annual Cash Flow Reinvestment Rate for DNA Link Inc (2020–2022)
Year-by-year capital reinvestment analysis for DNA Link Inc. See DNA Link Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 8.36x | ₩7.61 Billion | ₩910.27 Million | ₩4.93 Billion | ▲ +104.1% |
| 2020 | 4.09x | ₩3.48 Billion | ₩849.38 Million | ₩1.10 Billion | — |